Feasibility and Acceptability of Primary Palliative Care Intervention in Patients Undergoing Hematopoietic Stem Cell Transplantation

NANot yet recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 20, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

October 30, 2026

Conditions
Hematopoietic Cell TransplantHematologic Malignancy
Interventions
BEHAVIORAL

Primary palliative care

Enrolled patient participants will receive Sentinel prior to and during their hospitalization for HCT. Prior to HCT, a transplant clinician (nurse practitioner - NP) will conduct a focused PC visit to build rapport, manage expectations regarding HCT, review anticipated symptoms, and discuss illness coping strategies. During the HCT hospitalization, HCT physicians and advanced practice providers will incorporate PC domains into their routine care of patients undergoing HCT.

Trial Locations (1)

02152

Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

American Society of Transplantation and Cellular Therapy

UNKNOWN

lead

Massachusetts General Hospital

OTHER

NCT06676852 - Feasibility and Acceptability of Primary Palliative Care Intervention in Patients Undergoing Hematopoietic Stem Cell Transplantation | Biotech Hunter | Biotech Hunter